AL-DAWAA MEDICAL SERVICES COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.6 SAR | +2.58% |
|
+1.10% | -13.42% |
| Sales 2024 * | 6.12B 1.63B | Sales 2025 * | 6.57B 1.75B | Capitalization | 7.79B 2.08B |
|---|---|---|---|---|---|
| Net income 2024 * | 395M 105M | Net income 2025 * | 489M 130M | EV / Sales 2024 * | 1.48 x |
| Net Debt 2024 * | 1.27B 339M | Net Debt 2025 * | 1.18B 314M | EV / Sales 2025 * | 1.36 x |
| P/E ratio 2024 * |
19.7
x | P/E ratio 2025 * |
15.9
x | Employees | - |
| Yield 2024 * |
2.95% | Yield 2025 * |
3.64% | Free-Float | 34.18% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.58% | ||
| 1 week | +1.10% | ||
| Current month | -1.61% | ||
| 1 month | -8.31% | ||
| 3 months | -19.51% | ||
| 6 months | -1.08% | ||
| Current year | -13.42% |
1 week
87.80
92.10
1 month
87.8099.00
Current year
87.80121.60
1 year
76.70121.60
3 years
63.00121.60
5 years
63.00121.60
10 years
63.00121.60
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director/Board Member | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
Hassan Al-Somali
BRD | Director/Board Member | - | - |
Ibrahim Al-Rwyes
BRD | Director/Board Member | - | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.22% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 91.6 | +2.58% | 227,700 |
| 24-04-24 | 89.3 | +0.56% | 179,189 |
| 24-04-23 | 88.8 | -2.09% | 215,878 |
| 24-04-22 | 90.7 | -0.77% | 422,017 |
| 24-04-21 | 91.4 | +0.88% | 342,592 |
End-of-day quote Saudi Arabian S.E., April 24, 2024
More quotes
Al Dawaa Medical Services Company SJSC is a Saudi Arabia- based entity, which is primarily engaged in selling pharmaceutical and healthcare products. The Company is engaged in online wholesale of pharmaceutical products, wholesale of pharmaceutical goods, related pharmacy activities, pharmaceutical warehousing activities, and retail of medical equipment, among others. The Company operates in two segments: Retail, which includes the sale of goods to customers commonly at the store checkout for the sales via the Group's pharmacies; and Wholesale, which includes sale of goods to the wholesale customers. The Companyâs products include mum and baby, beauty care, personal care, health and wellness, medicine and treatments, and vitamins and healthy nutrition. The Company operates approximately four subsidiaries.
Sector
Drug Retailers
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
91.6
SAR
Average target price
116.3
SAR
Spread / Average Target
+26.92%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.42% | 2.08B | |
| -32.59% | 15.18B | |
| -31.97% | 10.1B | |
| +9.54% | 6.12B | |
| -11.41% | 5.97B | |
| -30.42% | 5.65B | |
| -0.88% | 4.71B | |
| +51.58% | 4.26B | |
| -12.22% | 3.58B | |
| -16.75% | 3.26B |
- Stock Market
- Equities
- 4163 Stock
